VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 676 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,922 | +78.7% | 1,372 | +100.0% | 0.00% | 0.0% |
| Q2 2023 | $20,656 | -27.8% | 686 | -22.4% | 0.00% | -50.0% |
| Q1 2023 | $28,598 | +12.9% | 884 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $25,335 | +20.6% | 884 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $21,000 | -12.5% | 884 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -54.7% | 884 | -36.1% | 0.00% | -50.0% |
| Q1 2022 | $53,000 | -17.2% | 1,384 | -30.7% | 0.00% | 0.0% |
| Q4 2021 | $64,000 | +12.3% | 1,998 | +4.2% | 0.00% | 0.0% |
| Q3 2021 | $57,000 | -33.7% | 1,918 | -23.8% | 0.00% | -42.9% |
| Q2 2021 | $86,000 | +7.5% | 2,518 | +2.4% | 0.01% | 0.0% |
| Q1 2021 | $80,000 | -10.1% | 2,458 | 0.0% | 0.01% | -12.5% |
| Q4 2020 | $89,000 | +21.9% | 2,458 | +32.3% | 0.01% | 0.0% |
| Q3 2020 | $73,000 | +942.9% | 1,858 | +838.4% | 0.01% | +700.0% |
| Q2 2020 | $7,000 | +40.0% | 198 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,000 | – | 198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |